<DOC>
	<DOCNO>NCT02951598</DOCNO>
	<brief_summary>The purpose study learn health care use , cost , clinical outcome time amyloid positive participant early stage AD United States . This study research purpose , intend treat medical condition . No study therapy ( y ) AD administer .</brief_summary>
	<brief_title>A Study Health Care Use Costs Participants With Early Stage Alzheimer 's Disease ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Presents within normal course outpatient care physician deem meet clinical criterion MCI due AD mild AD dementia . Fully inform write consent participant ( his/her legal representative ) . Study partner frequent contact participant willing accompany participant study observation . Fully inform write consent study partner ; person must willing serve study partner least 6 month year . Able communicate English and/or US Spanish . Able provide evidence amyloid testing . Has MiniMental State Examination ( MMSE ) score 20 great . Are currently enrol clinical trial involve investigational product type medical research judge scientifically medically compatible study baseline . Are investigator site personnel directly affiliate study and/or immediate family . Immediate family define spouse , parent , child , sibling , whether biological legally adopt . Lack evidence amyloid positivity prestudy test . Note : After baseline assessment , participant amyloid negativity identify part study continue postbaseline assessment . Are Lilly employee employee thirdparty organization ( TPO ) involve study require exclusion employee .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>